公司資料
TransMedics 股價、新聞與催化劑
- 股票代碼:
- TMDX
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
88.35 USD (-0.26%)
收盤價
最後更新: 2026年8月17日
2.37B USD
市值
股價為何變動
As of Aug 17, 2026, TMDX closed down 0.26% at $88.35. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
TransMedics is a transplant technology company focused on organ transport, preservation, and perfusion systems.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, TransMedics sits in specialized medical devices.
商業模式特徵
The company generates revenue through transplant logistics, device usage, and the expansion of its organ-management platform.
生技產業定位
TransMedics is a procedure-driven medtech name whose valuation is tied to adoption in the transplant workflow.
未來催化劑
- TransMedics's catalysts are OCS utilization in heart, lung, and liver transplant workflows, plus continued expansion of its organ-network footprint. The market will care about whether the platform keeps winning more procedures and more centers.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。